Article from Wisconsin Health News, July 17, 2019
A University of Wisconsin and the Medical College of Wisconsin researcher highlighted their work on retinal imaging at a Wisconsin Tech Council meeting last week.
The landscape of eye disease treatment has changed dramatically over the last decade, with more available treatments and promising research, said Joseph Carroll, a professor of ophthalmology at the Medical College of Wisconsin.
Carroll's work with Melissa Skala, a UW biomedical engineering professor, focuses largely on evaluating treatment outcomes. That involves “measuring when one cell has been lost, when two cells have been lost," he said.
“Conventional imaging can’t detect that, but we can,” he said.
Skala said there are no current methods for imaging the eye sufficiently enough to guide retinal surgery or detecting melanin, which can be used to identify disease earlier.
She said that they've modified existing eye technology so that it can guide surgery and see melanin in the eye.
They’re hoping to now “do some safety studies and then start to see what we can do in patients to start to quantify these melanin levels for the first time,” Skala said.